IronBridge Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

IronBridge Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$24.6M	Sell	160,025 -162,207	-50%	-$24.8M	1.49%	13
2016 Q4	$45.5M	Sell	322,232 -258	-0.1%	-$38K	2.04%	10
2016 Q3	$51.3M	Sell	322,490 -12,400	-4%	-$1.91M	2.35%	6
2016 Q2	$49.5M	Sell	334,890 -60	-0%	-$8.86K	2.17%	7
2016 Q1	$47.4M	Buy	334,950 +41,260	+14%	+$5.53M	1.91%	8
2015 Q4	$41.7M	Sell	293,690 -27,710	-9%	-$3.7M	1.64%	14
2015 Q3	$39.3M	Sell	321,400 -127,080	-28%	-$16.6M	1.54%	17
2015 Q2	$58.2M	Sell	448,480 -38,885	-8%	-$5.07M	1.75%	17
2015 Q1	$65.5M	Sell	487,365 -860	-0.2%	-$111K	1.86%	15
2014 Q4	$61.2M	Sell	488,225 -62,135	-11%	-$7.56M	1.71%	14
2014 Q3	$67M	Sell	550,360 -30,500	-5%	-$3.71M	1.78%	15
2014 Q2	$68.5M	Buy	580,860 +155,730	+37%	+$18.3M	1.68%	17
2014 Q1	$51.1M	Buy	+425,130	New	+$50.5M	1.11%	26

Other funds holding TMO

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

IronBridge Capital Management's TMO Position: Q1 2017 in Review

IronBridge Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 50% in Q1 2017, selling an estimated $24.8M and leaving 160,025 shares worth $24.6M. The position accounts for 1.49% of the portfolio, ranked #13.

IronBridge Capital Management first reported a position in TMO in Q1 2014 and has held it in 13 quarters since. The position peaked at $68.5M in Q2 2014. 1,135 funds tracked by Wall St. Rank hold TMO as of Q1 2017.

IronBridge Capital Management held 160,025 shares of Thermo Fisher Scientific worth $24.6M as of Q1 2017.
IronBridge Capital Management sold 162,207 Thermo Fisher Scientific shares in Q1 2017, an estimated $24.8M.
Thermo Fisher Scientific made up 1.49% of IronBridge Capital Management's portfolio in Q1 2017, its #13 holding.
IronBridge Capital Management first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 13 quarters since.
IronBridge Capital Management's Thermo Fisher Scientific position peaked at $68.5M in Q2 2014.
1,135 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2017.

Based on IronBridge Capital Management's 13F filing for Q1 2017, filed 10 May 2017.